Amide Technologies Analysis: $17M Raised
What is Amide Technologies?
Amide Technologies specializes in synthesizing peptides that are difficult to obtain through traditional methods. The company focuses on bridging the gap between solid phase peptide synthesis and biological expression, utilizing unnatural amino acids and artificial protein backbones. Their capabilities include reliable linear synthesis of peptides up to 120 amino acids and rapid delivery for drug discovery.
Location
750 Main St, Cambridge, Massachusetts 02139, United States
Employees
1-10
Founded
2016
Funding Status
Series A
Product Features & Capabilities
- Polyamide manufacturing
- Peptide synthesis
- Complex peptide manufacturing platform
- Urgent peptide order fulfillment
Use Cases
Accept peptide orders that other vendors refuse; Ship urgent peptide orders in less than a week; Synthesize linear peptides up to 120 amino acids; Provide access to large and unusual compounds; Support rapid design-build-test cycles for drug discovery
Other Considerations
Raised $16.5M to expedite drug discovery; Announced complex peptide manufacturing platform; Serves clients in the biopharmaceutical sector
See something that needs updating? Suggest edits to this profile.